China Stocks Rebound Slightly After Release of Key Data

Gene Linn |

hong kong china stocksIt could have been worse. Chinese inflation and other economic data released Tuesday was generally within expectations, a little higher here, a little lower there. After fear of rising inflation and slowing  growth put the market in a tailspin the last two weeks, China stocks in Hong Kong bounced higher minutes after release of the unexciting data.

The much anticipated consumer price inflation figure for May was 5.5%, up from 5.3% in April as expected. The producer price index gained slightly more than predicted, 6.8%. “This reflects that future inflation pressure will remain high,” Ben Kwong, chief operating officer of KGI Asia, told Equities.

Measures of Chinese economic growth were mixed, he said. Retail sales growth was a bit lower than expected; fixed asset investment and industrial production were somewhat higher.

“You look at the data along with macro-economic statistics released yesterday like new loan growth and money supply, and signs are the economy is not slowing very significantly,” Kwong said. “That will be treated as quite positive.

“If you curb inflation you need to tighten economic policy. If you slow growth too much there’s significant concern there will be a hard landing. But the data does not point to a hard landing.”

However, the rising inflation figures signal China will tighten the economic screws further, probably raising interest rates and bank reserve requirements again. Kwong and other analysts think inflation will peak at about 6.0% this month before retreating gradually.

With higher inflation in the offing and the U.S. economy still unsettled, Kwong sees little hope of a significant short-term rebound. And in fact on Tuesday Hong Kong blue chips could not hang onto gains posted right after the release of economic data. A shares in China and the index of Chinese companies in Hong Kong did, however, end higher.

The strong fixed asset investment growth helped cement and construction plays. Cement producer Anhui Conch (0914 in Hong Kong) surged 5.8%. Statistics also did not show any significant slowdown in property development, and some Chinese property plays like R & F (2777) rose 4-5%.  End

DAILY FIX - Chna Plays Helped by Economic Data

Hong Kong Blue Chips: -12, =0.05%, to 22,496, 06-14-11, Hang Seng Index

Chinese Stocks in Hong Kong: +55, +0.5% to 12,488, 06-14-11, HSCE Index

Shanghai Stocks: +1.1%, 2,730, 06-14-11, Shanghai Composite Index.

Chinese Stocks in the U.S.: -0.4 to 416.7, 06-13-11, Bank of New York Mellon, ADR Index-China

Insight: Chinese stocks in Hong Kong and on Mainland exchanges rose after inflation and other economic figures came in as expected Tuesday, but Hong Kong blue chips could not hold onto gains. The statistics boosted cement and construction plays and also helped Chinese property developers. KGI Research

Quotable: "Market View – Whether the technical rebound could persist depends on the economic data to be released today." BOCOM  International. 6-14-2011

Chinese Company to Watch: "Johnson Electric (179) retreated 7% since June 1, thus offering a good buying opportunity." Guoco Capital. 6-14-2011

Brokerages and analysts cited have disclaimers on their websites emphasizing their statements are for information only. They do not endorse my blog, and I don't endorse them.

For a list of Chinese companies sold in the U.S. and information on each company go to http://www.adrbnymellon.com/dr_country_profile.jsp?country=CN

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer

Companies

Symbol Name Price Change % Volume
CCE Coca-Cola European Partners plc 32.30 0.66 2.09 2,558,035

Comments

Private Markets

Lyft

Lyft matches drivers using their own personal vehicles with passengers who request rides through the smartphone app, and the passengers pay automatically through the app. When using Lyft, passengers have…

BioSculpture Technology, Inc.

BioSculpture Technology, Inc. (“BST”) is a commercial-stage medical device manufacturer of liposuction surgical instruments for surgeons. It offers the FDA-cleared Twin Cannula Assisted Liposuction ("TCAL") Airbrush Liposculptor II® controllers, Airbrush®…